Abstract
The relationship of thrombocytopenia to subsequent major adverse cardiovascular events (MACE) in non–ST-segment elevation acute coronary syndrome (NSTE-ACS) is unclear. A total of 1,510 consecutive patients with NSTE-ACS presenting to a teaching hospital in Hong Kong in 2014 to 2018 were analyzed
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
